Using natural products to decipher essential host-parasite interactions in visceral leishmaniasis. - 1 project summary: 2 visceral leishmaniasis is a vector-borne neglected tropical disease (NTD)…

Active Project Grant Awarded Last action

Award ID
R16AI189394
Recipient
Awarding agency
Obligated
$260,000

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 28% complete
Place of performance
Durango, CO, USA

Award details come from USAspending.gov.

About this award

The National Institute of Allergy and Infectious Diseases awarded Fort Lewis College $260,000 on September 10, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the mechanism of action of sulforaphane in inhibiting leishmanial parasite replication in macrophage host cells.

The project, titled "Using Natural Products to Decipher Essential Host-Parasite Interactions in Visceral Leishmaniasis," will identify how sulforaphane modifies host and parasite cellular pathways to reduce intracellular amastigote replication. Research activities include two specific aims: determining the extent to which sulforaphane activates nuclear factor erythroid 2-related factor 2 (NRF2)-dependent and -independent pathways to inhibit Leishmania replication, and identifying how sulforaphane modifies host autophagic flux to decrease parasite levels. The project will engage undergraduate research students in these investigations.

Fort Lewis College, a public liberal arts institution in Durango, Colorado, serves as the recipient and place of performance. The award period runs through August 31, 2029. This is a Project Grant, classified as assistance funding supporting basic biomedical research in infectious diseases and related areas at eligible public and nonprofit institutions.

Description

Using natural products to decipher essential host-parasite interactions in visceral leishmaniasis. - 1 project summary: 2 visceral leishmaniasis is a vector-borne neglected tropical disease (NTD) caused by leishmania 3 donovani and leishmania infantum. During infection, leishmania parasites alter host responses in 4 innate immune cells, such as macrophages (MΦ's), to ensure parasite survival and replication in the 5 parasitophorous vacuole (PV). Understanding the cellular pathways that are subverted during 6 leishmania infections provides a unique opportunity to elucidate the host-parasite interactions 7 necessary for successful infection. The long-term goal of this project is to identify natural products 8 that modify host-parasite interactions required for parasite replication while engaging a diverse group 9 of undergraduate research students. The overall objective is to identify the mechanism of action of 10 sulforaphane (SFN) to determine its antileishmanial properties. We hypothesize that SFN modifies 11 host and parasite pathways to inhibit intracellular amastigote replication. Our hypothesis is based on 12 our recently published work that establishes SFN is an effective anti-parasitic compound that inhibits 13 both promastigote and amastigote replication. The rationale underlying this proposal is that a 14 systematic study of the mechanisms controlled by SFN will provide a better appreciation of how 15 leishmania successfully replicate inside MΦ's. The overall objective will be accomplished by pursing 16 the following two specific aims: 1) identify the extent to which SFN activates nuclear factor erythroid 17 2-related factor 2 (NRF2)-dependent and -independent pathways to inhibit leishmania replication, 18 and 2) identify the extent to which SFN modifies host autophagic flux to decrease parasite levels. 19 under the first aim, our working hypothesis is that SFN sustains host NRF2-dependent gene 20 expression during the infection to reduce amastigote replication. The NRF2 pathway will be activated 21 post-infection through SFN and specific NRF2 activators in both wild-type and NRF2 knockout MΦ's. 22 amastigote levels will be quantified through fluorescence microscopy. Host and parasite 23 transcriptomics will be quantified through bioinformatics analysis. The second aim, based on 24 preliminary data, indicates that SFN inhibits autophagy to increase the number of autophagosomes 25 thereby reducing the number of intracellular amastigotes. Autophagic flux will be quantified through 26 fluorescence microscopy and protein analysis of autophagy related proteins in WT and LAMP2 KO 27 MΦ's. Amastigote levels will be quantified, and essential host proteins associated with amastigote 28 maturation in the PV will be determined by confocal microscopy. This proposal is significant because 29 the resulting mechanistic understanding of host-parasite interactions will clarify the role of NRF2 and 30 autophagy within the innate immune cells during parasitic infections within the PV.

Transactions

Action Obligated Date
Amendment $130,000
Original award $130,000

Quick answers

Who received award R16AI189394?

R16AI189394 was awarded to Fort Lewis College by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2025.

How much is award R16AI189394 worth?

$260,000 has been obligated on R16AI189394.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award